{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "# %matplotlib notebook\n",
    "%matplotlib inline"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>org_study_id</th>\n",
       "      <th>nct_id</th>\n",
       "      <th>url</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>official_title</th>\n",
       "      <th>source</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>detailed_description</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>last_known_status</th>\n",
       "      <th>...</th>\n",
       "      <th>phase</th>\n",
       "      <th>study_type</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>allocation</th>\n",
       "      <th>intervention_model</th>\n",
       "      <th>primary_purpose</th>\n",
       "      <th>masking</th>\n",
       "      <th>study_first_submitted</th>\n",
       "      <th>study_first_submitted_qc</th>\n",
       "      <th>last_update_submitted</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCRR-M01RR01070-0506</td>\n",
       "      <td>NCT00000102</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT00000102</td>\n",
       "      <td>Congenital Adrenal Hyperplasia: Calcium Channe...</td>\n",
       "      <td>**None**</td>\n",
       "      <td>National Center for Research Resources (NCRR)</td>\n",
       "      <td>This study will test the ability of extended r...</td>\n",
       "      <td>This protocol is designed to assess both acute...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>**None**</td>\n",
       "      <td>...</td>\n",
       "      <td>Phase 1/Phase 2</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>No</td>\n",
       "      <td>**None**</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>Double</td>\n",
       "      <td>1999-11-03</td>\n",
       "      <td>November 3, 1999</td>\n",
       "      <td>June 23, 2005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCRR-M01RR00400-0587</td>\n",
       "      <td>NCT00000104</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT00000104</td>\n",
       "      <td>Does Lead Burden Alter Neuropsychological Deve...</td>\n",
       "      <td>**None**</td>\n",
       "      <td>National Center for Research Resources (NCRR)</td>\n",
       "      <td>Inner city children are at an increased risk f...</td>\n",
       "      <td>**None**</td>\n",
       "      <td>Completed</td>\n",
       "      <td>**None**</td>\n",
       "      <td>...</td>\n",
       "      <td>**None**</td>\n",
       "      <td>Observational</td>\n",
       "      <td>No</td>\n",
       "      <td>**None**</td>\n",
       "      <td>**None**</td>\n",
       "      <td>**None**</td>\n",
       "      <td>**None**</td>\n",
       "      <td>1999-11-03</td>\n",
       "      <td>November 3, 1999</td>\n",
       "      <td>June 23, 2005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2002LS032</td>\n",
       "      <td>NCT00000105</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT00000105</td>\n",
       "      <td>Vaccination With Tetanus and KLH to Assess Imm...</td>\n",
       "      <td>Vaccination With Tetanus Toxoid and Keyhole Li...</td>\n",
       "      <td>Masonic Cancer Center, University of Minnesota</td>\n",
       "      <td>The purpose of this study is to learn how the ...</td>\n",
       "      <td>Patients will receive each vaccine once only c...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>**None**</td>\n",
       "      <td>...</td>\n",
       "      <td>**None**</td>\n",
       "      <td>Observational</td>\n",
       "      <td>No</td>\n",
       "      <td>**None**</td>\n",
       "      <td>**None**</td>\n",
       "      <td>**None**</td>\n",
       "      <td>**None**</td>\n",
       "      <td>1999-11-03</td>\n",
       "      <td>November 3, 1999</td>\n",
       "      <td>November 27, 2017</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCRR-M01RR03186-9943</td>\n",
       "      <td>NCT00000106</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT00000106</td>\n",
       "      <td>41.8 Degree Centigrade Whole Body Hyperthermia...</td>\n",
       "      <td>**None**</td>\n",
       "      <td>National Center for Research Resources (NCRR)</td>\n",
       "      <td>Recently a non-toxic system for whole body hyp...</td>\n",
       "      <td>**None**</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Active, not recruiting</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>No</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>**None**</td>\n",
       "      <td>2000-01-18</td>\n",
       "      <td>January 18, 2000</td>\n",
       "      <td>June 23, 2005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCRR-M01RR00109-0737</td>\n",
       "      <td>NCT00000107</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT00000107</td>\n",
       "      <td>Body Water Content in Cyanotic Congenital Hear...</td>\n",
       "      <td>**None**</td>\n",
       "      <td>National Center for Research Resources (NCRR)</td>\n",
       "      <td>Adults with cyanotic congenital heart disease ...</td>\n",
       "      <td>**None**</td>\n",
       "      <td>Completed</td>\n",
       "      <td>**None**</td>\n",
       "      <td>...</td>\n",
       "      <td>**None**</td>\n",
       "      <td>Observational</td>\n",
       "      <td>No</td>\n",
       "      <td>**None**</td>\n",
       "      <td>**None**</td>\n",
       "      <td>**None**</td>\n",
       "      <td>**None**</td>\n",
       "      <td>2000-01-18</td>\n",
       "      <td>January 18, 2000</td>\n",
       "      <td>June 23, 2005</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows Ã— 22 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           org_study_id       nct_id  \\\n",
       "0  NCRR-M01RR01070-0506  NCT00000102   \n",
       "1  NCRR-M01RR00400-0587  NCT00000104   \n",
       "2             2002LS032  NCT00000105   \n",
       "3  NCRR-M01RR03186-9943  NCT00000106   \n",
       "4  NCRR-M01RR00109-0737  NCT00000107   \n",
       "\n",
       "                                           url  \\\n",
       "0  https://clinicaltrials.gov/show/NCT00000102   \n",
       "1  https://clinicaltrials.gov/show/NCT00000104   \n",
       "2  https://clinicaltrials.gov/show/NCT00000105   \n",
       "3  https://clinicaltrials.gov/show/NCT00000106   \n",
       "4  https://clinicaltrials.gov/show/NCT00000107   \n",
       "\n",
       "                                         brief_title  \\\n",
       "0  Congenital Adrenal Hyperplasia: Calcium Channe...   \n",
       "1  Does Lead Burden Alter Neuropsychological Deve...   \n",
       "2  Vaccination With Tetanus and KLH to Assess Imm...   \n",
       "3  41.8 Degree Centigrade Whole Body Hyperthermia...   \n",
       "4  Body Water Content in Cyanotic Congenital Hear...   \n",
       "\n",
       "                                      official_title  \\\n",
       "0                                           **None**   \n",
       "1                                           **None**   \n",
       "2  Vaccination With Tetanus Toxoid and Keyhole Li...   \n",
       "3                                           **None**   \n",
       "4                                           **None**   \n",
       "\n",
       "                                           source  \\\n",
       "0   National Center for Research Resources (NCRR)   \n",
       "1   National Center for Research Resources (NCRR)   \n",
       "2  Masonic Cancer Center, University of Minnesota   \n",
       "3   National Center for Research Resources (NCRR)   \n",
       "4   National Center for Research Resources (NCRR)   \n",
       "\n",
       "                                       brief_summary  \\\n",
       "0  This study will test the ability of extended r...   \n",
       "1  Inner city children are at an increased risk f...   \n",
       "2  The purpose of this study is to learn how the ...   \n",
       "3  Recently a non-toxic system for whole body hyp...   \n",
       "4  Adults with cyanotic congenital heart disease ...   \n",
       "\n",
       "                                detailed_description  overall_status  \\\n",
       "0  This protocol is designed to assess both acute...       Completed   \n",
       "1                                           **None**       Completed   \n",
       "2  Patients will receive each vaccine once only c...      Terminated   \n",
       "3                                           **None**  Unknown status   \n",
       "4                                           **None**       Completed   \n",
       "\n",
       "        last_known_status          ...                     phase  \\\n",
       "0                **None**          ...           Phase 1/Phase 2   \n",
       "1                **None**          ...                  **None**   \n",
       "2                **None**          ...                  **None**   \n",
       "3  Active, not recruiting          ...                       NaN   \n",
       "4                **None**          ...                  **None**   \n",
       "\n",
       "       study_type has_expanded_access  allocation   intervention_model  \\\n",
       "0  Interventional                  No    **None**  Parallel Assignment   \n",
       "1   Observational                  No    **None**             **None**   \n",
       "2   Observational                  No    **None**             **None**   \n",
       "3  Interventional                  No  Randomized  Parallel Assignment   \n",
       "4   Observational                  No    **None**             **None**   \n",
       "\n",
       "  primary_purpose   masking study_first_submitted study_first_submitted_qc  \\\n",
       "0       Treatment    Double            1999-11-03         November 3, 1999   \n",
       "1        **None**  **None**            1999-11-03         November 3, 1999   \n",
       "2        **None**  **None**            1999-11-03         November 3, 1999   \n",
       "3       Treatment  **None**            2000-01-18         January 18, 2000   \n",
       "4        **None**  **None**            2000-01-18         January 18, 2000   \n",
       "\n",
       "  last_update_submitted  \n",
       "0         June 23, 2005  \n",
       "1         June 23, 2005  \n",
       "2     November 27, 2017  \n",
       "3         June 23, 2005  \n",
       "4         June 23, 2005  \n",
       "\n",
       "[5 rows x 22 columns]"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "studies_full_df = pd.read_csv(\n",
    "    r\"c:\\Dev\\04. Python\\03. XML converter of FDA list\\goodDB\\05. 2018Sep22_11-50-07\\FDA_DB_MAIN_TABLE_2018Sep22_11-50-07.csv\",\n",
    "    parse_dates = [\"study_first_submitted\"]\n",
    ")\n",
    "studies_full_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 285016 entries, 0 to 285015\n",
      "Data columns (total 22 columns):\n",
      "org_study_id                285016 non-null object\n",
      "nct_id                      285016 non-null object\n",
      "url                         285016 non-null object\n",
      "brief_title                 285016 non-null object\n",
      "official_title              285016 non-null object\n",
      "source                      285016 non-null object\n",
      "brief_summary               285016 non-null object\n",
      "detailed_description        285016 non-null object\n",
      "overall_status              285016 non-null object\n",
      "last_known_status           285016 non-null object\n",
      "start_date                  285016 non-null object\n",
      "completion_date             285016 non-null object\n",
      "phase                       197879 non-null object\n",
      "study_type                  284218 non-null object\n",
      "has_expanded_access         285016 non-null object\n",
      "allocation                  285016 non-null object\n",
      "intervention_model          285016 non-null object\n",
      "primary_purpose             285016 non-null object\n",
      "masking                     285016 non-null object\n",
      "study_first_submitted       285016 non-null datetime64[ns]\n",
      "study_first_submitted_qc    285016 non-null object\n",
      "last_update_submitted       285016 non-null object\n",
      "dtypes: datetime64[ns](1), object(21)\n",
      "memory usage: 47.8+ MB\n"
     ]
    }
   ],
   "source": [
    "studies_full_df.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "286"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "culled_studies_full_info_df = pd.DataFrame(studies_full_df[::1000])\n",
    "len(culled_studies_full_info_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>org_study_id</th>\n",
       "      <th>nct_id</th>\n",
       "      <th>url</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>official_title</th>\n",
       "      <th>source</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>detailed_description</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>last_known_status</th>\n",
       "      <th>...</th>\n",
       "      <th>phase</th>\n",
       "      <th>study_type</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>allocation</th>\n",
       "      <th>intervention_model</th>\n",
       "      <th>primary_purpose</th>\n",
       "      <th>masking</th>\n",
       "      <th>study_first_submitted</th>\n",
       "      <th>study_first_submitted_qc</th>\n",
       "      <th>last_update_submitted</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCRR-M01RR01070-0506</td>\n",
       "      <td>NCT00000102</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT00000102</td>\n",
       "      <td>Congenital Adrenal Hyperplasia: Calcium Channe...</td>\n",
       "      <td>**None**</td>\n",
       "      <td>National Center for Research Resources (NCRR)</td>\n",
       "      <td>This study will test the ability of extended r...</td>\n",
       "      <td>This protocol is designed to assess both acute...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>**None**</td>\n",
       "      <td>...</td>\n",
       "      <td>Phase 1/Phase 2</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>No</td>\n",
       "      <td>**None**</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>Double</td>\n",
       "      <td>1999-11-03</td>\n",
       "      <td>November 3, 1999</td>\n",
       "      <td>June 23, 2005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1000</th>\n",
       "      <td>AI-06-001</td>\n",
       "      <td>NCT00001131</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT00001131</td>\n",
       "      <td>Effectiveness of Interleukin-2 (IL-2) Plus Ant...</td>\n",
       "      <td>Procedure for Initiation, Administration, and ...</td>\n",
       "      <td>National Institute of Allergy and Infectious D...</td>\n",
       "      <td>The purpose of this study is to find out if th...</td>\n",
       "      <td>At the time of initial HIV infection, CD4 cell...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>**None**</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>No</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>2000-01-17</td>\n",
       "      <td>August 30, 2001</td>\n",
       "      <td>May 14, 2015</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2000</th>\n",
       "      <td>116A</td>\n",
       "      <td>NCT00002307</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT00002307</td>\n",
       "      <td>A Comparison of Zidovudine (AZT) and Stavudine...</td>\n",
       "      <td>A Double-Blind Comparison of Zidovudine (AZT) ...</td>\n",
       "      <td>Bristol-Myers Squibb</td>\n",
       "      <td>To compare stavudine (d4T) and zidovudine (AZT...</td>\n",
       "      <td>**None**</td>\n",
       "      <td>Completed</td>\n",
       "      <td>**None**</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>No</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>Double</td>\n",
       "      <td>1999-11-02</td>\n",
       "      <td>August 30, 2001</td>\n",
       "      <td>August 4, 2011</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3000</th>\n",
       "      <td>CDR0000066511</td>\n",
       "      <td>NCT00003474</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT00003474</td>\n",
       "      <td>Antineoplaston Therapy in Treating Adults With...</td>\n",
       "      <td>Phase II Study of Antineoplastons A10 and AS2-...</td>\n",
       "      <td>Burzynski Research Institute</td>\n",
       "      <td>RATIONALE: Current therapies for Glioblastoma ...</td>\n",
       "      <td>OVERVIEW: This is a single arm, open-label stu...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>**None**</td>\n",
       "      <td>...</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>No</td>\n",
       "      <td>**None**</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>1999-11-01</td>\n",
       "      <td>January 26, 2003</td>\n",
       "      <td>March 7, 2018</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4000</th>\n",
       "      <td>000092</td>\n",
       "      <td>NCT00004853</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT00004853</td>\n",
       "      <td>Comparison of Filgrastim and Filgrastim SD/01i...</td>\n",
       "      <td>A Randomized Trial of Filgrastim-SD/01 vs. Fil...</td>\n",
       "      <td>National Institutes of Health Clinical Center ...</td>\n",
       "      <td>Filgrastim (granulocyte colony-stimulating fac...</td>\n",
       "      <td>Background:\\n\\n        -  Filgrastim (granuloc...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>**None**</td>\n",
       "      <td>...</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>No</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>2000-03-04</td>\n",
       "      <td>March 4, 2000</td>\n",
       "      <td>September 1, 2018</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows Ã— 22 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "              org_study_id       nct_id  \\\n",
       "0     NCRR-M01RR01070-0506  NCT00000102   \n",
       "1000             AI-06-001  NCT00001131   \n",
       "2000                  116A  NCT00002307   \n",
       "3000         CDR0000066511  NCT00003474   \n",
       "4000                000092  NCT00004853   \n",
       "\n",
       "                                              url  \\\n",
       "0     https://clinicaltrials.gov/show/NCT00000102   \n",
       "1000  https://clinicaltrials.gov/show/NCT00001131   \n",
       "2000  https://clinicaltrials.gov/show/NCT00002307   \n",
       "3000  https://clinicaltrials.gov/show/NCT00003474   \n",
       "4000  https://clinicaltrials.gov/show/NCT00004853   \n",
       "\n",
       "                                            brief_title  \\\n",
       "0     Congenital Adrenal Hyperplasia: Calcium Channe...   \n",
       "1000  Effectiveness of Interleukin-2 (IL-2) Plus Ant...   \n",
       "2000  A Comparison of Zidovudine (AZT) and Stavudine...   \n",
       "3000  Antineoplaston Therapy in Treating Adults With...   \n",
       "4000  Comparison of Filgrastim and Filgrastim SD/01i...   \n",
       "\n",
       "                                         official_title  \\\n",
       "0                                              **None**   \n",
       "1000  Procedure for Initiation, Administration, and ...   \n",
       "2000  A Double-Blind Comparison of Zidovudine (AZT) ...   \n",
       "3000  Phase II Study of Antineoplastons A10 and AS2-...   \n",
       "4000  A Randomized Trial of Filgrastim-SD/01 vs. Fil...   \n",
       "\n",
       "                                                 source  \\\n",
       "0         National Center for Research Resources (NCRR)   \n",
       "1000  National Institute of Allergy and Infectious D...   \n",
       "2000                               Bristol-Myers Squibb   \n",
       "3000                       Burzynski Research Institute   \n",
       "4000  National Institutes of Health Clinical Center ...   \n",
       "\n",
       "                                          brief_summary  \\\n",
       "0     This study will test the ability of extended r...   \n",
       "1000  The purpose of this study is to find out if th...   \n",
       "2000  To compare stavudine (d4T) and zidovudine (AZT...   \n",
       "3000  RATIONALE: Current therapies for Glioblastoma ...   \n",
       "4000  Filgrastim (granulocyte colony-stimulating fac...   \n",
       "\n",
       "                                   detailed_description overall_status  \\\n",
       "0     This protocol is designed to assess both acute...      Completed   \n",
       "1000  At the time of initial HIV infection, CD4 cell...      Completed   \n",
       "2000                                           **None**      Completed   \n",
       "3000  OVERVIEW: This is a single arm, open-label stu...      Completed   \n",
       "4000  Background:\\n\\n        -  Filgrastim (granuloc...      Completed   \n",
       "\n",
       "     last_known_status          ...                     phase      study_type  \\\n",
       "0             **None**          ...           Phase 1/Phase 2  Interventional   \n",
       "1000          **None**          ...                       NaN  Interventional   \n",
       "2000          **None**          ...                       NaN  Interventional   \n",
       "3000          **None**          ...                   Phase 2  Interventional   \n",
       "4000          **None**          ...                   Phase 1  Interventional   \n",
       "\n",
       "     has_expanded_access  allocation       intervention_model primary_purpose  \\\n",
       "0                     No    **None**      Parallel Assignment       Treatment   \n",
       "1000                  No  Randomized      Parallel Assignment       Treatment   \n",
       "2000                  No  Randomized  Single Group Assignment       Treatment   \n",
       "3000                  No    **None**  Single Group Assignment       Treatment   \n",
       "4000                  No  Randomized      Parallel Assignment       Treatment   \n",
       "\n",
       "                masking study_first_submitted study_first_submitted_qc  \\\n",
       "0                Double            1999-11-03         November 3, 1999   \n",
       "1000  None (Open Label)            2000-01-17          August 30, 2001   \n",
       "2000             Double            1999-11-02          August 30, 2001   \n",
       "3000  None (Open Label)            1999-11-01         January 26, 2003   \n",
       "4000  None (Open Label)            2000-03-04            March 4, 2000   \n",
       "\n",
       "     last_update_submitted  \n",
       "0            June 23, 2005  \n",
       "1000          May 14, 2015  \n",
       "2000        August 4, 2011  \n",
       "3000         March 7, 2018  \n",
       "4000     September 1, 2018  \n",
       "\n",
       "[5 rows x 22 columns]"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "culled_studies_full_info_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>org_study_id</th>\n",
       "      <th>nct_id</th>\n",
       "      <th>url</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>official_title</th>\n",
       "      <th>source</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>detailed_description</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>last_known_status</th>\n",
       "      <th>...</th>\n",
       "      <th>allocation</th>\n",
       "      <th>intervention_model</th>\n",
       "      <th>primary_purpose</th>\n",
       "      <th>masking</th>\n",
       "      <th>study_first_submitted</th>\n",
       "      <th>study_first_submitted_qc</th>\n",
       "      <th>last_update_submitted</th>\n",
       "      <th>qwe1</th>\n",
       "      <th>study_first_submitted_month</th>\n",
       "      <th>study_first_submitted_year</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCRR-M01RR01070-0506</td>\n",
       "      <td>NCT00000102</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT00000102</td>\n",
       "      <td>Congenital Adrenal Hyperplasia: Calcium Channe...</td>\n",
       "      <td>**None**</td>\n",
       "      <td>National Center for Research Resources (NCRR)</td>\n",
       "      <td>This study will test the ability of extended r...</td>\n",
       "      <td>This protocol is designed to assess both acute...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>**None**</td>\n",
       "      <td>...</td>\n",
       "      <td>**None**</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>Double</td>\n",
       "      <td>1999-11-03</td>\n",
       "      <td>November 3, 1999</td>\n",
       "      <td>June 23, 2005</td>\n",
       "      <td>1</td>\n",
       "      <td>11</td>\n",
       "      <td>1999</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1000</th>\n",
       "      <td>AI-06-001</td>\n",
       "      <td>NCT00001131</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT00001131</td>\n",
       "      <td>Effectiveness of Interleukin-2 (IL-2) Plus Ant...</td>\n",
       "      <td>Procedure for Initiation, Administration, and ...</td>\n",
       "      <td>National Institute of Allergy and Infectious D...</td>\n",
       "      <td>The purpose of this study is to find out if th...</td>\n",
       "      <td>At the time of initial HIV infection, CD4 cell...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>**None**</td>\n",
       "      <td>...</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>2000-01-17</td>\n",
       "      <td>August 30, 2001</td>\n",
       "      <td>May 14, 2015</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>2000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2000</th>\n",
       "      <td>116A</td>\n",
       "      <td>NCT00002307</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT00002307</td>\n",
       "      <td>A Comparison of Zidovudine (AZT) and Stavudine...</td>\n",
       "      <td>A Double-Blind Comparison of Zidovudine (AZT) ...</td>\n",
       "      <td>Bristol-Myers Squibb</td>\n",
       "      <td>To compare stavudine (d4T) and zidovudine (AZT...</td>\n",
       "      <td>**None**</td>\n",
       "      <td>Completed</td>\n",
       "      <td>**None**</td>\n",
       "      <td>...</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>Double</td>\n",
       "      <td>1999-11-02</td>\n",
       "      <td>August 30, 2001</td>\n",
       "      <td>August 4, 2011</td>\n",
       "      <td>1</td>\n",
       "      <td>11</td>\n",
       "      <td>1999</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3000</th>\n",
       "      <td>CDR0000066511</td>\n",
       "      <td>NCT00003474</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT00003474</td>\n",
       "      <td>Antineoplaston Therapy in Treating Adults With...</td>\n",
       "      <td>Phase II Study of Antineoplastons A10 and AS2-...</td>\n",
       "      <td>Burzynski Research Institute</td>\n",
       "      <td>RATIONALE: Current therapies for Glioblastoma ...</td>\n",
       "      <td>OVERVIEW: This is a single arm, open-label stu...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>**None**</td>\n",
       "      <td>...</td>\n",
       "      <td>**None**</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>1999-11-01</td>\n",
       "      <td>January 26, 2003</td>\n",
       "      <td>March 7, 2018</td>\n",
       "      <td>1</td>\n",
       "      <td>11</td>\n",
       "      <td>1999</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4000</th>\n",
       "      <td>000092</td>\n",
       "      <td>NCT00004853</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT00004853</td>\n",
       "      <td>Comparison of Filgrastim and Filgrastim SD/01i...</td>\n",
       "      <td>A Randomized Trial of Filgrastim-SD/01 vs. Fil...</td>\n",
       "      <td>National Institutes of Health Clinical Center ...</td>\n",
       "      <td>Filgrastim (granulocyte colony-stimulating fac...</td>\n",
       "      <td>Background:\\n\\n        -  Filgrastim (granuloc...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>**None**</td>\n",
       "      <td>...</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>2000-03-04</td>\n",
       "      <td>March 4, 2000</td>\n",
       "      <td>September 1, 2018</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows Ã— 25 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "              org_study_id       nct_id  \\\n",
       "0     NCRR-M01RR01070-0506  NCT00000102   \n",
       "1000             AI-06-001  NCT00001131   \n",
       "2000                  116A  NCT00002307   \n",
       "3000         CDR0000066511  NCT00003474   \n",
       "4000                000092  NCT00004853   \n",
       "\n",
       "                                              url  \\\n",
       "0     https://clinicaltrials.gov/show/NCT00000102   \n",
       "1000  https://clinicaltrials.gov/show/NCT00001131   \n",
       "2000  https://clinicaltrials.gov/show/NCT00002307   \n",
       "3000  https://clinicaltrials.gov/show/NCT00003474   \n",
       "4000  https://clinicaltrials.gov/show/NCT00004853   \n",
       "\n",
       "                                            brief_title  \\\n",
       "0     Congenital Adrenal Hyperplasia: Calcium Channe...   \n",
       "1000  Effectiveness of Interleukin-2 (IL-2) Plus Ant...   \n",
       "2000  A Comparison of Zidovudine (AZT) and Stavudine...   \n",
       "3000  Antineoplaston Therapy in Treating Adults With...   \n",
       "4000  Comparison of Filgrastim and Filgrastim SD/01i...   \n",
       "\n",
       "                                         official_title  \\\n",
       "0                                              **None**   \n",
       "1000  Procedure for Initiation, Administration, and ...   \n",
       "2000  A Double-Blind Comparison of Zidovudine (AZT) ...   \n",
       "3000  Phase II Study of Antineoplastons A10 and AS2-...   \n",
       "4000  A Randomized Trial of Filgrastim-SD/01 vs. Fil...   \n",
       "\n",
       "                                                 source  \\\n",
       "0         National Center for Research Resources (NCRR)   \n",
       "1000  National Institute of Allergy and Infectious D...   \n",
       "2000                               Bristol-Myers Squibb   \n",
       "3000                       Burzynski Research Institute   \n",
       "4000  National Institutes of Health Clinical Center ...   \n",
       "\n",
       "                                          brief_summary  \\\n",
       "0     This study will test the ability of extended r...   \n",
       "1000  The purpose of this study is to find out if th...   \n",
       "2000  To compare stavudine (d4T) and zidovudine (AZT...   \n",
       "3000  RATIONALE: Current therapies for Glioblastoma ...   \n",
       "4000  Filgrastim (granulocyte colony-stimulating fac...   \n",
       "\n",
       "                                   detailed_description overall_status  \\\n",
       "0     This protocol is designed to assess both acute...      Completed   \n",
       "1000  At the time of initial HIV infection, CD4 cell...      Completed   \n",
       "2000                                           **None**      Completed   \n",
       "3000  OVERVIEW: This is a single arm, open-label stu...      Completed   \n",
       "4000  Background:\\n\\n        -  Filgrastim (granuloc...      Completed   \n",
       "\n",
       "     last_known_status            ...              allocation  \\\n",
       "0             **None**            ...                **None**   \n",
       "1000          **None**            ...              Randomized   \n",
       "2000          **None**            ...              Randomized   \n",
       "3000          **None**            ...                **None**   \n",
       "4000          **None**            ...              Randomized   \n",
       "\n",
       "           intervention_model primary_purpose            masking  \\\n",
       "0         Parallel Assignment       Treatment             Double   \n",
       "1000      Parallel Assignment       Treatment  None (Open Label)   \n",
       "2000  Single Group Assignment       Treatment             Double   \n",
       "3000  Single Group Assignment       Treatment  None (Open Label)   \n",
       "4000      Parallel Assignment       Treatment  None (Open Label)   \n",
       "\n",
       "     study_first_submitted study_first_submitted_qc last_update_submitted  \\\n",
       "0               1999-11-03         November 3, 1999         June 23, 2005   \n",
       "1000            2000-01-17          August 30, 2001          May 14, 2015   \n",
       "2000            1999-11-02          August 30, 2001        August 4, 2011   \n",
       "3000            1999-11-01         January 26, 2003         March 7, 2018   \n",
       "4000            2000-03-04            March 4, 2000     September 1, 2018   \n",
       "\n",
       "     qwe1 study_first_submitted_month study_first_submitted_year  \n",
       "0       1                          11                       1999  \n",
       "1000    1                           1                       2000  \n",
       "2000    1                          11                       1999  \n",
       "3000    1                          11                       1999  \n",
       "4000    1                           3                       2000  \n",
       "\n",
       "[5 rows x 25 columns]"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# culled_studies_full_info_df[\"study_first_submitted\"].dt.month\n",
    "culled_studies_full_info_df = culled_studies_full_info_df.assign(\n",
    "    study_first_submitted_month = np.int64(culled_studies_full_info_df[\"study_first_submitted\"].dt.month))\n",
    "culled_studies_full_info_df = culled_studies_full_info_df.assign(\n",
    "    study_first_submitted_year = np.int64(culled_studies_full_info_df[\"study_first_submitted\"].dt.year))\n",
    "\n",
    "# culled_studies_full_info_df[\"study_first_submitted_month\"] = culled_studies_full_info_df[\"study_first_submitted\"].values.astype('datetime64[M]')\n",
    "culled_studies_full_info_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 286 entries, 0 to 285000\n",
      "Data columns (total 24 columns):\n",
      "org_study_id                   286 non-null object\n",
      "nct_id                         286 non-null object\n",
      "url                            286 non-null object\n",
      "brief_title                    286 non-null object\n",
      "official_title                 286 non-null object\n",
      "source                         286 non-null object\n",
      "brief_summary                  286 non-null object\n",
      "detailed_description           286 non-null object\n",
      "overall_status                 286 non-null object\n",
      "last_known_status              286 non-null object\n",
      "start_date                     286 non-null object\n",
      "completion_date                286 non-null object\n",
      "phase                          182 non-null object\n",
      "study_type                     285 non-null object\n",
      "has_expanded_access            286 non-null object\n",
      "allocation                     286 non-null object\n",
      "intervention_model             286 non-null object\n",
      "primary_purpose                286 non-null object\n",
      "masking                        286 non-null object\n",
      "study_first_submitted          286 non-null datetime64[ns]\n",
      "study_first_submitted_qc       286 non-null object\n",
      "last_update_submitted          286 non-null object\n",
      "qwe1                           286 non-null int64\n",
      "study_first_submitted_month    286 non-null int64\n",
      "dtypes: datetime64[ns](1), int64(2), object(21)\n",
      "memory usage: 53.7+ KB\n"
     ]
    }
   ],
   "source": [
    "culled_studies_full_info_df.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x1e70b759dd8>"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "culled_studies_full_info_df[\"study_first_submitted_month\"].hist(bins=12)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "count     286.000000\n",
       "mean     2011.975524\n",
       "std         4.464609\n",
       "min      1999.000000\n",
       "25%      2009.000000\n",
       "50%      2013.000000\n",
       "75%      2016.000000\n",
       "max      2018.000000\n",
       "Name: study_first_submitted_year, dtype: float64"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "culled_studies_full_info_df[\"study_first_submitted_year\"].describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "12"
      ]
     },
     "execution_count": 50,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "culled_studies_full_info_df[\"study_first_submitted_year\"].nunique()\n",
    "culled_studies_full_info_df[\"study_first_submitted_month\"].nunique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x1e7105a65c0>"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1440x720 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "fig = plt.subplots(figsize=(20, 10))\n",
    "plt.subplot(121)\n",
    "culled_studies_full_info_df[\"study_first_submitted_year\"].hist(bins=21, \n",
    "                                                               **{\"label\":\"HALLO\", \"histtype\":\"stepfilled\",\n",
    "                                                                  \"range\": (1995, 2020), \"align\":\"mid\"\n",
    "                                                                          })\n",
    "plt.subplot(122)\n",
    "culled_studies_full_info_df[\"study_first_submitted_month\"].hist(bins=12)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>study_first_submitted_month</th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>23</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>25</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>23</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                             nct_id\n",
       "study_first_submitted_month        \n",
       "1                                23\n",
       "2                                26\n",
       "3                                25\n",
       "4                                21\n",
       "5                                23"
      ]
     },
     "execution_count": 73,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "studies_by_month = pd.DataFrame(culled_studies_full_info_df.groupby(\"study_first_submitted_month\").count())\n",
    "studies_by_month.drop(columns=[\n",
    "    \"org_study_id\", \n",
    "    \"study_first_submitted_year\", \n",
    "    \"url\", \n",
    "    \"brief_title\", \n",
    "    \"official_title\", \n",
    "    \"source\", \n",
    "    \"brief_summary\", \n",
    "    \"detailed_description\", \n",
    "    \"overall_status\", \n",
    "    \"last_known_status\", \n",
    "    \"start_date\", \n",
    "    \"completion_date\", \n",
    "    \"phase\", \n",
    "    \"study_type\", \n",
    "    \"has_expanded_access\", \n",
    "    \"allocation\", \n",
    "    \"intervention_model\", \n",
    "    \"primary_purpose\", \n",
    "    \"masking\", \n",
    "    \"study_first_submitted\", \n",
    "    \"study_first_submitted_qc\", \n",
    "    \"last_update_submitted\", \n",
    "    \"qwe1\"\n",
    "    ], inplace=True)\n",
    "studies_by_month.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x1e711b8a7b8>"
      ]
     },
     "execution_count": 79,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "studies_by_month.plot.bar()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>study_first_submitted_year</th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1999</th>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2000</th>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2001</th>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2002</th>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2003</th>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                            nct_id\n",
       "study_first_submitted_year        \n",
       "1999                             3\n",
       "2000                             3\n",
       "2001                             2\n",
       "2002                             1\n",
       "2003                             2"
      ]
     },
     "execution_count": 81,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "studies_by_year = pd.DataFrame(culled_studies_full_info_df.groupby(\"study_first_submitted_year\").count())\n",
    "studies_by_year.drop(columns=[\n",
    "    \"org_study_id\", \n",
    "    \"study_first_submitted_month\", \n",
    "    \"url\", \n",
    "    \"brief_title\", \n",
    "    \"official_title\", \n",
    "    \"source\", \n",
    "    \"brief_summary\", \n",
    "    \"detailed_description\", \n",
    "    \"overall_status\", \n",
    "    \"last_known_status\", \n",
    "    \"start_date\", \n",
    "    \"completion_date\", \n",
    "    \"phase\", \n",
    "    \"study_type\", \n",
    "    \"has_expanded_access\", \n",
    "    \"allocation\", \n",
    "    \"intervention_model\", \n",
    "    \"primary_purpose\", \n",
    "    \"masking\", \n",
    "    \"study_first_submitted\", \n",
    "    \"study_first_submitted_qc\", \n",
    "    \"last_update_submitted\", \n",
    "    \"qwe1\"\n",
    "    ], inplace=True)\n",
    "studies_by_year.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x1e711c308d0>"
      ]
     },
     "execution_count": 82,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAXQAAAEaCAYAAAABnax5AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADl0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uIDIuMi4yLCBodHRwOi8vbWF0cGxvdGxpYi5vcmcvhp/UCwAAHu5JREFUeJzt3XucHHWZ7/HPNxcJd0IYIRLCRESNHJMQZqNyE5Sb4uGyoiwCoquE1SDglRzXI7KuGtYLLsddz4EFg1xEkYsIIuFEICALkvuFABGIGAwQIMidJfDsH78a6Ywz09XdNdOVyvf9evVrqqvr9/RTNd1PV//6V1WKCMzMbMM3pN0JmJlZMVzQzcwqwgXdzKwiXNDNzCrCBd3MrCJc0M3MKsIF3cysIlzQzcwqwgXdzKwihg3mk2233XbR2dk5mE9pZrbBmzdv3uMR0VFvuUEt6J2dncydO3cwn9LMbIMn6Q95lnOXi5lZRbigm5lVhAu6mVlFDGofem9efvllVq1axYsvvtjuVNpmxIgRjBkzhuHDh7c7FTPbgLW9oK9atYott9ySzs5OJLU7nUEXETzxxBOsWrWKcePGtTsdM9uAtb3L5cUXX2TUqFEbZTEHkMSoUaM26m8oZlaMthd0YKMt5t029vU3s2KUoqCbmVnr2t6H3lPn9OsKjbdyxqGFxjOzjVee+tTOmuM99AatXLmSSy+9tN9l5s6dyymnnNLrY52dnTz++OMDkZqZbeRc0BuUp6B3dXVxzjnnDFJGZmaJCzqpSI8fP54TTzyR3XbbjYMOOogXXniB3//+9xxwwAFMnDiRyZMnc//99zN9+nRuvfVWJk2axNlnn91rvJtvvpkPfOADADzxxBMcdNBB7L777px00klExGCumpltROoWdEkjJP1O0iJJyySdmc0fJ+lOSSsk/VTS6wY+3YGzYsUKpk2bxrJly9hmm2244oorOPbYY5k2bRqLFi3i9ttvZ/To0cyYMYN99tmHhQsX8tnPfrZu3DPPPJO9996bBQsWcNhhh/HQQw8NwtqY2cYozx76S8B7ImIiMAk4RNI7gbOAsyNiV2At8ImBS3PgjRs3jkmTJgGwxx578OCDD/Lwww9z5JFHAulozs0226zhuHPmzOG4444D4NBDD2XkyJHFJW1mVqNuQY/k2ezu8OwWwHuAn2fzLwSOGJAMB8kmm2zyl+mhQ4eydu3awmJ7nLmZDYZcwxYlDQXmAW8C/g24H3gqItZli6wCduyj7VRgKsDYsWPrPldZhhlutdVWjBkzhquvvpojjjiCl156iVdeeYUtt9ySZ555Jnecfffdl0suuYSvfOUrXH/99YV+UJiZ1cr1o2hEvBIRk4AxwBRgfG+L9dH23Ijoioiujo66F9wolYsuuohzzjmHCRMmsOeee/LII48wYcIEhg0bxsSJE/v8UbTWGWecwZw5c5g8eTKzZs3K9aFmZtYMNTrqQtIZwPPA6cAOEbFO0ruAr0XEwf217erqip5XLFq+fDnjx/f2+bBx8XYwK792HVgkaV5EdNVbLs8olw5J22TTmwIHAMuBm4CjssVOAH7RfLpmZtaqPH3oo4ELs370IcDPIuJaSXcDl0n6Z2ABcP4A5llKN9xwA6effvp688aNG8dVV13VpozMbGNWt6BHxGJg917mP0DqT29ZRGyQI0EOPvhgDj64316mXHywkZkVoe1Hio4YMYInnnhioy1q3Re4GDFiRLtTMbMNXNvPtjhmzBhWrVrFmjVr2p1K23Rfgs7MrBVtL+jDhw/3pdfMzArQ9i4XMzMrhgu6mVlFuKCbmVWEC7qZWUW4oJuZVYQLuplZRbigm5lVhAu6mVlFuKCbmVWEC7qZWUW4oJuZVYQLuplZRbigm5lVhAu6mVlFuKCbmVWEC7qZWUW4oJuZVYQLuplZRbT9EnRmZnl0Tr+u38dXzjh0kDIpL++hm5lVhAu6mVlF1C3oknaSdJOk5ZKWSTo1m/81SQ9LWpjd3j/w6ZqZWV/y9KGvAz4fEfMlbQnMk3Rj9tjZEfGdgUvPzMzyqlvQI2I1sDqbfkbScmDHgU7MzMwa09AoF0mdwO7AncBewMmSPgrMJe3Fr+2lzVRgKsDYsWNbTNfMrHlVHymT+0dRSVsAVwCnRcTTwA+BXYBJpD347/bWLiLOjYiuiOjq6OgoIGUzM+tNroIuaTipmF8SEVcCRMSjEfFKRLwKnAdMGbg0zcysnjyjXAScDyyPiO/VzB9ds9iRwNLi0zMzs7zy9KHvBRwPLJG0MJv3ZeAYSZOAAFYCJw1IhmZmlkueUS63AerloV8Vn46ZmTXLR4qamVWEC7qZWUW4oJuZVYQLuplZRbigm5lVhAu6mVlFuKCbmVWEC7qZWUW4oJuZVYQLuplZRbigm5lVhAu6mVlFuKCbmVWEC7qZWUU0dE1RM9v41LsOJ9S/FmcRMaw+76GbmVWEC7qZWUW4oJuZVYQLuplZRbigm5lVhAu6mVlFeNiimdkgGsghnN5DNzOrCBd0M7OKcEE3M6uIugVd0k6SbpK0XNIySadm87eVdKOkFdnfkQOfrpmZ9SXPHvo64PMRMR54JzBN0tuA6cDsiNgVmJ3dNzOzNqlb0CNidUTMz6afAZYDOwKHAxdmi10IHDFQSZqZWX0N9aFL6gR2B+4Eto+I1ZCKPvD6PtpMlTRX0tw1a9a0lq2ZmfUpd0GXtAVwBXBaRDydt11EnBsRXRHR1dHR0UyOZmaWQ66CLmk4qZhfEhFXZrMflTQ6e3w08NjApGhmZnnkGeUi4HxgeUR8r+aha4ATsukTgF8Un56ZmeWV59D/vYDjgSWSFmbzvgzMAH4m6RPAQ8CHBiZFMzPLo25Bj4jbAPXx8HuLTcfMzJrlk3OZDZCyXEezXh6+lmd1+NB/M7OKcEE3M6sIF3Qzs4pwQTczqwgXdDOzinBBNzOrCA9btEqqylC9qqyHDQ7voZuZVYQLuplZRbigm5lVhAu6mVlFuKCbmVWEC7qZWUW4oJuZVYQLuplZRbigm5lVhAu6mVlFuKCbmVWEC7qZWUW4oJuZVYTPtmjWB5/p0DY03kM3M6sIF3Qzs4qoW9AlXSDpMUlLa+Z9TdLDkhZmt/cPbJpmZlZPnj30mcAhvcw/OyImZbdfFZuWmZk1qm5Bj4g5wJODkIuZmbWglT70kyUtzrpkRva1kKSpkuZKmrtmzZoWns7MzPrTbEH/IbALMAlYDXy3rwUj4tyI6IqIro6OjiafzszM6mmqoEfEoxHxSkS8CpwHTCk2LTMza1RTBV3S6Jq7RwJL+1rWzMwGR90jRSX9BNgP2E7SKuAMYD9Jk4AAVgInDWCOZmaWQ92CHhHH9DL7/AHIxczMWuAjRc3MKsIF3cysIlzQzcwqwgXdzKwiXNDNzCrCBd3MrCJc0M3MKsIF3cysInxNUSsdX8vTrDneQzczqwgXdDOzinBBNzOrCBd0M7OKcEE3M6sIj3Kx9XiEidmGy3voZmYV4YJuZlYRLuhmZhXhgm5mVhEu6GZmFeGCbmZWER62aIWqN+wRPPTRbKB4D93MrCJc0M3MKqJuQZd0gaTHJC2tmbetpBslrcj+jhzYNM3MrJ48e+gzgUN6zJsOzI6IXYHZ2X0zM2ujugU9IuYAT/aYfThwYTZ9IXBEwXmZmVmDmu1D3z4iVgNkf19fXEpmZtaMAf9RVNJUSXMlzV2zZs1AP52Z2Uar2YL+qKTRANnfx/paMCLOjYiuiOjq6Oho8unMzKyeZgv6NcAJ2fQJwC+KScfMzJqVZ9jiT4D/BN4iaZWkTwAzgAMlrQAOzO6bmVkb1T30PyKO6eOh9xaci5mZtcBHipqZVYQLuplZRbigm5lVhAu6mVlFuKCbmVWEC7qZWUW4oJuZVYQLuplZRbigm5lVhAu6mVlFuKCbmVWEC7qZWUW4oJuZVYQLuplZRbigm5lVhAu6mVlFuKCbmVWEC7qZWUW4oJuZVYQLuplZRbigm5lVhAu6mVlFuKCbmVWEC7qZWUW4oJuZVcSwVhpLWgk8A7wCrIuIriKSMjOzxrVU0DP7R8TjBcQxM7MWuMvFzKwiWi3oAcySNE/S1N4WkDRV0lxJc9esWdPi05mZWV9aLeh7RcRk4H3ANEn79lwgIs6NiK6I6Oro6Gjx6czMrC8tFfSI+FP29zHgKmBKEUmZmVnjmi7okjaXtGX3NHAQsLSoxMzMrDGtjHLZHrhKUnecSyPi14VkZWZmDWu6oEfEA8DEAnMxM7MWeNiimVlFuKCbmVWEC7qZWUW4oJuZVYQLuplZRbigm5lVhAu6mVlFFHH63KZ1Tr+u7jIrZxzaUox67c3MqsJ76GZmFeGCbmZWES7oZmYV4YJuZlYRLuhmZhXhgm5mVhFtHbZYFmUY+lhEDmVYDzNrH++hm5lVhAu6mVlFuKCbmVWEC7qZWUW4oJuZVYQLuplZRXjYYgGKOGukmVmrvIduZlYRLuhmZhXRUkGXdIikeyX9XtL0opIyM7PGNV3QJQ0F/g14H/A24BhJbysqMTMza0wre+hTgN9HxAMR8V/AZcDhxaRlZmaNUkQ011A6CjgkIj6Z3T8eeEdEnNxjuanA1OzuW4B7+wm7HfB4UwlVL0YZcihLjDLkUESMMuRQlhhlyKEsMfK03zkiOuoFamXYonqZ91efDhFxLnBuroDS3IjoaiGnysQoQw5liVGGHIqIUYYcyhKjDDmUJUYROXRrpctlFbBTzf0xwJ9aS8fMzJrVSkG/C9hV0jhJrwP+DrimmLTMzKxRTXe5RMQ6SScDNwBDgQsiYlmL+eTqmtlIYpQhh7LEKEMORcQoQw5liVGGHMoSo4gcgBZ+FDUzs3LxkaJmZhXhgm5mVhEu6GZmFeGCbmZWERv8+dAlbQ0cAuxIOrDpT8ANEfFUAbEPjIgbcyy3FdAREff3mD8hIhbnfK4dACLiEUkdwD7Ava2MHJL0zYj4cgvtxwG7A3dHxD05lh8LPBYRL0oS8DFgMnA3cF5ErMsR4zBgVkS82GzeWZx9gUcj4l5JewPvBJZHRP2T16f2W5BeVzsB64AVWV6vNpDDW0mnw6h9bV4TEcsbWpk2kzQFiIi4Kztf0yHAPRHxqxZi/jgiPlpYkhuImiHef4qI/y/pI8CewHLg3Ih4uaX4G/IoF0kfBc4AZgEPZ7PHAAcCZ0bEj1uM/1BEjK2zzIeB7wOPAcOBj0XEXdlj8yNico7nOQmYTjr69ixSIVwG7AX8S0ScnyPGOT1nAccDPwaIiFNyxLg6Io7Ipg/P1utm0gvuWxExs077pcCUiHhe0lnALsDVwHuyHP4+Rw4vAM8B1wM/IX04v1KvXY8Y3yeda2gYaVjte7N47wYWRMQX67T/MPBFYBGwP3A76dvs24FjI2JJjhxOB44hneNoVTZ7DOnNfFlEzGhknXqJ//GI+FHOZd9K+lC5MyKerZl/SET8uk7bM0gn4BsG3Ai8g/SaOID0v/lGjufveXyKSNv1NwARcVie9egRc2/S/3hpRMzK2eYdpA/1pyVtSnrPde9wfDMi/lyn/SnAVRHxx0bzrYlxCWlbbgY8BWwBXEl6jSoiTmg2NgAR0bYb6Z/6A+AXwBXADOBNDbS/F9iml/kjgftyxrimj9svgedytF8IjM6mpwD3AH+b3V+QM4cl2T94FPAssEPNeizMGWMVcDHwUeCE7LamezpnjAU107cD47Lp7YBFOdrfXTM9DxhSc79u++4csvU+EZgNPAr8X+DdDbwulpGKxmbAWmCzbP5wUgGo135xTZvtSIULYAJwe84c7gOG9zL/dcCKvOvST/yHci53SvY+uRpYCRxe89j8nK/Nodm2fBrYKpu/KbA4Zw7zs9fmfqQP1f2A1dl0rv8r8Lua6ROz990ZwG+B6Q28LoZl0+eSdlj2zuJcmaP9n0nfsm4FPk36Vt7o/21x9ndY9toemt1X3u3Z361tXS6SZgDbk960OwAPAvcDl2ddBZfnCUMv548BXqX3c830Zh/gOFIh7Rl7So72QyNiNUBE/E7S/sC1ksb0kVtvXo6I54HnJd0fEY9k8dZKyhtjPPB10tfhL0bEw5LOiIgLc7anR77DIuLBLI/HJeXpavijpPdExG9IxWMn4A+SRjWSQ0SsBc4Dzsu6oj4MzJA0JiJ26r/5X2JETc7d6/Uq+X43EvBCNv0c8Pos6OKsey2PV4E3AH/oMX909lj9JKS+uutEeu/kcSKwR0Q8K6kT+Lmkzoj4V/K9R9ZF+obU/dp8GiAiXsj5mgDoAk4F/pH02lwo6YWIuCVne0gfxt2mAgdGxBpJ3wHuIO0M1jMkXuv264rXvj3fJmlhjvYPAHuQvp0cDZwpaR7pm+SVEfFMnhyybpfNSR+SWwNPApuw/jo2pZ196IdGxNsBJF0G3BIRX5T0c9InYJ6C/g1gvqRZQPfXoLGkLpev58zjDuD53l5ckvo7M2S3ZyTtEln/eUSslrQfaY9ot5w5vCppeKT+s79cfFTSCHL+cJ29mE6TtAdwsaTr8ratMVHS06Q3+iaSdojUp/860l5aPZ8Efizpa6S9mYWSuve4P5czh/WKTPbhdg5wjqSdc8a4TtKtwAjgP4CfSbqDtEc4J0f7XwG/lnQLqbvhcgBJ2/bMrx+nAbMlrWD91+abgJP7bLW+7YGDSd8yaon0DSqPoZF1s0TEyuy1+fNsW+ZZl/+StFm2w7HHXxJIv13lKuiRfnc4W9Ll2d9Habz2DJE0kvSaVkSsyWI/J6nubzOZpTVdVYskdUXEXElvBvL0XUe2LrOAWZKGk14fxwDfAeqeDRE4n/QtfijpA+5ySQ+QfuO5LOd69JthW26k/slts+mxwB21X40aiDOS1C/5eeAL2fTIQVyPicCuvcwfTupvzRNjLL1/Pd8ROKCJnARMAy4uaB23Ad7VwPLjST8GfpDU5zqkgbb7FZTzu4B3ZtO7ZK+ND+fNBXh/1ubAmnlDgE0ayGFI9kb9IHBUNj20gfbnA3v38dilOWP8BpjUY94w0m8rr+Ro3+v6krqi3t7k/+ZQUp91I21WkvaQH8z+dndLbkH+bsmtgZmknoA7SUX8AeAWYGKO9n12oQKbNrAubwDekE1vk702pjSzLXve2vajqKSjgX8h9e+9FfhURFyXjfD414j4SAOxtqdmJEFEPNpEPi3FKEMOZYlRhhyKiFFEDn3E3SJqfpwcSFnX37rIuvF6PLZXRPy2hdgtr0erMSRtBmwfWfdgzjZbAm8kfbCtyvt/lfTmiLivuUxzxW99e7aroMNfvsK+kXTlo4aHGUqaRPrBbGvSj4IijSR4Cvh0RMzPEWN34IdZjNqRMrli9MihZ/tPRcSCBtdjIGIUsS3q5lFQDm2PUUQOdeLXHT2VI0YZimkR61GVbVFEDi1vi7aOQ4+IJyW9Edg/6wdbETnGO9eYCZwUEXfWzpT0TuBHpO6Qen7UYoz+cpiZM4eBjlHEtsiTRxE5lCFGyzlI6us3A5G6CVp1N6mrbkBjFLEeVdkWRbQf6G3RzlEu7wa+S9rr2YM0/GikpJeB4yPfWM/Ne77pACLiDkmb50yl1RhlyKEsMcqQQxExisjhm8C3SQcl9ZTrx+qSFNOW16OIGGXYFgUV4yK2Z5/auYf+feCgSEOPxgHfi4i9JB1I+jHooBwxrs9Gc/yY10YS7EQai93vARMFxihDDmWJUYYciohRRA7zgasjYl7PByR9MmeMMhTTItajKtuiiByK2BZ9auePoosjYkI2PRS4K7JxoZKWRUSuIX+S3sdrh1eL1Jd+TTRwWHKrMcqQQ1lilCGHMqyHpLcAT0Y2vK7HY9vn+SFO0u3AZ/p48/8xcozJbzVGQetRlW1RRA4tb4t+47exoF9AGj0wm/TGeTgiPpf9aj0/It7alsTMSqIsxbQMyrAtNohtGQWMfWzmRhqn/WnSof8n8tohsJsCO+eMsTXpCLHlwBPZbXk2769OCTAQMcqQQ1lilCGHEq7HPc3GKMOtiPWoyrYoy/bs79a20+dGxMsR8e8RcXJEnBfZCZgi4oWI6Hm4dF9+RjqKbv+IGBURo0jnh3mKfEeaFhGjDDmUJUYZcijbeuzXI8bavDEkbS1phqR7JD2R3ZZn87YZpBgtr0cRMcqwLYrIgWK2Z9/a+Em1BfBPwFLSYeJrSIfhf6yBGPc281iRMcqQQ1lilCGHiq3HDcDpZEdFZvN2yObdOBgxvC0Kz6HlbdHfrZ0XuLiEdNjtIcCZpPN1HE8ak/7NnDH+IOlLSkf0AakvS+nUpXlPcdlqjDLkUJYYZcihSuvRGRFnRc1RnhHxSEScRf4x063G8LYoNocitkWf2lnQOyNiZkSsiojvAYdFxArg48Df5oxxNOmUs7dIWivpSdK5mrclnbdjMGKUIYeyxChDDlVajzIUU2+LYnMoYlv0rdVd/GZvpLPF7Z1N/0+yc043+tWDdB6YA4Atesw/ZLBilCGHssQoQw5VWQ/SiefOIv2AtpZ0mtXl2bxtBzGGt0VBORS1PfuM3WqApp84XSzgd6Qfmm4D3pzN7wBOyRmjpZP3FxGjDDmUJUYZcqjSemTLtrWYelsU3r6QbdFn/FYDDMQN+HjO5ZZ0b1igE5gLnJrdb+RqQU3HKEMOZYlRhhwqth5tL6beFoXn0PK26O9W1otEn0k6CVI9rZ68v4gYZcihLDHKkEOV1qPVqw0VEcPbotgcitgWfWrbj6KSFvdxW0L+y2s9onSqUwCyDfUBspPvD1KMMuRQlhhlyKGIGGXIAXq8+UnX4nyfpO/RZAFpIoa3RbE5FLEt+tbqLn6zN9IFUicBO/e4dZIuJpAnxhhqxoT2eGyvwYhRhhzKEqMMOVRsPVq62lARMbwtCs+h5W3R362d53I5H/hRRNzWy2OXRgNXLDKrIhVwtaEiYpRBGbbFhrAt23rFIjMzK047DywyM7MCuaCbmVWEC7qZWUW4oNt6JJ2mdJGRRts1dcVzST/Jhqt+VtI/STqggbb7SdqzmeftJ2arV26/PfvbKekjNfMnSXp/E/FultTVSk628SjrgUXWPqcBFwPPD/QTSdoB2DMidq6z3NDIzpffw37As6TzApVCRHR/wHQCHwEuze5PArqA3JfRa5d+treVnPfQN2KSNpd0naRFkpZKOgN4A3CTpJuyZZ6tWf4oSTOz6XGS/lPSXZK+XrPMRZIOr7l/iaTD+khhFvB6SQsl7SNppqSjsnYrJX1V0m3AhySdIunubG/+suxIvX8APtvdvo91/FC2boskzcnmfUzSD2qWuTY7Yq/7/nclzZc0W1JHNu9mSWdLmqN0UYO/kXSlpBWS/rmmbff2mgHsk+V2Ounc/0dn94/Otv0F2fZb0L3NJG2ard9iST8lXcGrr//fJySdXXP/xOwgFyQdJ+l32fP9P6Xr9iLph5LmSlom6cyatutt776e00qu1YHsvm24N+CDwHk197cmnaNiu5p5z9ZMHwXMzKavAT6aTU/rXg54N+mq5t3xHgSG9fH8ncDSmvszgaOy6ZXAl2oe+xOwSTa9Tfb3a8AX6qzjEmDHHu0+BvygZplrSVeQgXSd22Oz6a92L0c6xelZ2fSpWT6jgU1IF5AeVbu9SN8erq15jp7P+U3guO68gPuAzYHPARdk8yeQrjDf1ce6bQ7cDwzP7t9OOtpwPPDLmvn/XvO/2jb7OzRbpwm9bW/fNsyb99A3bkuAAySdJWmfiPhzA233An6STV/UPTMibgHeJOn1wDHAFRGxrsn8flozvRi4RNJxpCKX12+BmZJOJBWxel6ted6Lgb1rHrsm+7sEWBYRqyPiJdKFWupe8b2Hg4DpkhaSCusI0kUS9s2el4hYTFrvXkXEc6SjFz8g6a2kAr4EeC+wB3BXFv+9wBuzZh+WNB9YAOwGvK0mZO32tg2Q+9A3YhFxn6Q9gPcD35I0q7fFaqZH9PNYrYuAY4G/A/6+hRSfq5k+lFTsDgP+t6Td8gSIiH+Q9I6s/UKl82isY/3uxp7rtV6ImumXsr+v1kx332/0vSTggxFx73ozpZ7PWc9/AF8mnaO7+4R2Ai6MiP/VI/Y44AvA30TE2qz7rHbda7e3bYC8h74Rk/QG4PmIuBj4DjAZeAbYsmaxRyWNlzQEOLJm/m9JBRtS8a41k/TjKhGxrIA8hwA7RcRNwJdIXRRb9JJrb213iYg7I+KrwOOkPemVwCRJQyTtBEypaTKE1LUE6UfNvzo1RU49c+t5/wbgM8oquKTds/lzyLanpP9B6nbpU0TcSVqnj/DaN6bZwFHZtyQkbat0Nr+tSEX7z0pX3Xlfk+tmJeU99I3b24FvS3oVeBn4FPAu4HpJqyNif2A6qY/5j6QLem+RtT0VuFTSqcAVtUEj4lFJy0nnjS7CUOBiSVuT9j7PjoinJP2SdOrRw4HPRMStvbT9tqRds3azgUXZ/AdJXSdLgfk1yz8H7CZpHuni5Uc3mfNiYJ2kRaQPuAt5rYvlW8DXge8Di7OivpJ01r0fAj+StBhYSLoITD0/I500ai1ARNwt6SvArOzD8GVgWkTcIWkBsIzUTdT2c49YsXwuFyuc0jj2JcDkBvvlrQmSriV9yM1udy7WXu5ysUIpHRh0D/B/XMwHlqRtJN0HvOBibuA9dBsEkg4mXUi31oMRcWRvyzf5HP/IX4+fvjwivlHUc7STpDtJQyRrHZ+NajEDXNDNzCrDXS5mZhXhgm5mVhEu6GZmFeGCbmZWEf8NBx8b/J779zcAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "studies_by_year.plot.bar()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
